Table 1.

Summary of Various Telemedicine‐Based CHC Programs

Article	Type of TM Subjects	Number of Subjects	Study Design	SVR	Treatment Type	Country
Arora et al.2	Rural	TM n = 261	Prospective cohort study	TM 58%	Interferon and ribavirin	USA
		Clinic n = 146		Clinic 58%
Nazareth et al.11	Rural	TM n = 50	Prospective cohort study	TM 71%	Interferon and ribavirin	Australia
		Clinic n = 559		Clinic 59%
Rossaro et al.12	Rural	TM n = 40	Retrospective cohort study	TM 55%	Interferon and ribavirin	USA
		Clinic n = 40		Clinic 43%
Beste et al.3	Rural veterans	TM n = 6,431	Prospective cohort study	TM 58%	Interferon +/– ribavirin, DAA	USA
		Clinic n = 32,322		Clinic 54%
Cooper et al.4	Rural	TM n = 157	Retrospective cohort study	TM 95%	DAA	Canada
		Clinic n = 1,130		Clinic 95%
Sterling et al.13	Incarcerated	TM n = 84	Prospective cohort study	TM 95%	DAA	USA
		Clinic n = 240		Clinic 94%
Talal et al.14	OST	TM n = 62	Prospective cohort study	TM 93%	DAA	USA
Papaluca et al.15	Incarcerated	TM n = 313	Prospective cohort study	TM 96%	DAA	Australia

Abbreviations: OST, opioid substitution therapy; TM, telemedicine.